About
Sarepta Therapeutics Inc (NASDAQ:SRPT) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results
Mar 25 2026
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Mar 24 2026
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1
Mar 19 2026
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®
Mar 16 2026
Sarepta Announces that Screening and Enrollment are Underway in ENDEAVOR Cohort 8 to Evaluate Enhanced Immunosuppression Regimen as Part of ELEVIDYS Gene Therapy for Non-Ambulant Individuals with Duchenne
Financials
Revenue
$2.2 B
Market Cap
$2.44 B
EPS
-7.13
Google Übersetzer